A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Xin Zhang, Jie Jin et al.|Journal of Hematology & Oncology|2020Cited by 50
Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathwayYan Chen, Guoan Chen, Hong Chang et al.|Scientific Reports|2015Cited by 31
PFKP silencing suppresses tumor growth via the AXL-MET axisHuijie Zhao, Guoan Chen|International Journal of Biological Sciences|2024Cited by 4